333 related articles for article (PubMed ID: 36986633)
1. Recent Progress of Lipid Nanoparticles-Based Lipophilic Drug Delivery: Focus on Surface Modifications.
Seo Y; Lim H; Park H; Yu J; An J; Yoo HY; Lee T
Pharmaceutics; 2023 Feb; 15(3):. PubMed ID: 36986633
[TBL] [Abstract][Full Text] [Related]
2. Recent Updates on Applications of Lipid-Based Nanoparticles for Site- Specific Drug Delivery.
Agrawal S; Garg A; Varshney V
Pharm Nanotechnol; 2022; 10(1):24-41. PubMed ID: 35249522
[TBL] [Abstract][Full Text] [Related]
3. Chemistry of Lipid Nanoparticles for RNA Delivery.
Eygeris Y; Gupta M; Kim J; Sahay G
Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635
[TBL] [Abstract][Full Text] [Related]
4. Challenges in Oral Drug Delivery and Applications of Lipid Nanoparticles as Potent Oral Drug Carriers for Managing Cardiovascular Risk Factors.
Okur NÜ; Siafaka PI; Gökçe EH
Curr Pharm Biotechnol; 2021; 22(7):892-905. PubMed ID: 32753006
[TBL] [Abstract][Full Text] [Related]
5. Exploring LIPIDs for their potential to improves bioavailability of lipophilic drugs candidates: A review.
Preeti ; Sambhakar S; Saharan R; Narwal S; Malik R; Gahlot V; Khalid A; Najmi A; Zoghebi K; Halawi MA; Albratty M; Mohan S
Saudi Pharm J; 2023 Dec; 31(12):101870. PubMed ID: 38053738
[TBL] [Abstract][Full Text] [Related]
6. Solid lipid matrix mediated nanoarchitectonics for improved oral bioavailability of drugs.
Banerjee S; Pillai J
Expert Opin Drug Metab Toxicol; 2019 Jun; 15(6):499-515. PubMed ID: 31104522
[No Abstract] [Full Text] [Related]
7. Lipid Nanoparticles─From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement.
Tenchov R; Bird R; Curtze AE; Zhou Q
ACS Nano; 2021 Nov; 15(11):16982-17015. PubMed ID: 34181394
[TBL] [Abstract][Full Text] [Related]
8. Nanostructured Lipid Carriers- A Versatile Carrier for Oral Delivery of Lipophilic Drugs.
Patel P; Patel M
Recent Pat Nanotechnol; 2021; 15(2):154-164. PubMed ID: 32912129
[TBL] [Abstract][Full Text] [Related]
9. Lipid-based colloidal nanoparticles for applications in targeted vaccine delivery.
Khan MS; Baskoy SA; Yang C; Hong J; Chae J; Ha H; Lee S; Tanaka M; Choi Y; Choi J
Nanoscale Adv; 2023 Mar; 5(7):1853-1869. PubMed ID: 36998671
[TBL] [Abstract][Full Text] [Related]
10. Optimization of DOTAP/chol Cationic Lipid Nanoparticles for mRNA, pDNA, and Oligonucleotide Delivery.
Sun M; Dang UJ; Yuan Y; Psaras AM; Osipitan O; Brooks TA; Lu F; Di Pasqua AJ
AAPS PharmSciTech; 2022 May; 23(5):135. PubMed ID: 35534697
[TBL] [Abstract][Full Text] [Related]
11. Solid lipid nanoparticles and nanostructured lipid carriers: a review of the methods of manufacture and routes of administration.
Akbari J; Saeedi M; Ahmadi F; Hashemi SMH; Babaei A; Yaddollahi S; Rostamkalaei SS; Asare-Addo K; Nokhodchi A
Pharm Dev Technol; 2022 Jun; 27(5):525-544. PubMed ID: 35635506
[TBL] [Abstract][Full Text] [Related]
12. Solid Lipid Nanoparticles: A Potential Option for Enhancing Oral Bioavailability of Highly Soluble and Poorly Permeable (BCS Class III) Drugs.
Sri Rekha M ; Sangeetha S ; Seetha Devi A
Curr Drug Deliv; 2023; 20(3):223-236. PubMed ID: 35443896
[TBL] [Abstract][Full Text] [Related]
13. Solid Lipid Nanoparticles: Peculiar Strategy to Deliver Bio-Proactive Molecules.
Minocha N; Sharma N; Verma R; Kaushik D; Pandey P
Recent Pat Nanotechnol; 2023; 17(3):228-242. PubMed ID: 35301957
[TBL] [Abstract][Full Text] [Related]
14. Engineered therapeutic proteins for sustained-release drug delivery systems.
Nguyen TTK; Pham KY; Yook S
Acta Biomater; 2023 Nov; 171():131-154. PubMed ID: 37717712
[TBL] [Abstract][Full Text] [Related]
15. Potential of Lipid Nanoparticles (SLNs and NLCs) in Enhancing Oral Bioavailability of Drugs with Poor Intestinal Permeability.
Talegaonkar S; Bhattacharyya A
AAPS PharmSciTech; 2019 Feb; 20(3):121. PubMed ID: 30805893
[TBL] [Abstract][Full Text] [Related]
16. The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery.
Cheng X; Lee RJ
Adv Drug Deliv Rev; 2016 Apr; 99(Pt A):129-137. PubMed ID: 26900977
[TBL] [Abstract][Full Text] [Related]
17. siRNA Functionalized Lipid Nanoparticles (LNPs) in Management of Diseases.
Kalita T; Dezfouli SA; Pandey LM; Uludag H
Pharmaceutics; 2022 Nov; 14(11):. PubMed ID: 36432711
[TBL] [Abstract][Full Text] [Related]
18. Solid lipid nanoparticles for hydrophilic drugs.
Mirchandani Y; Patravale VB; S B
J Control Release; 2021 Jul; 335():457-464. PubMed ID: 34048841
[TBL] [Abstract][Full Text] [Related]
19. A close collaboration of chitosan with lipid colloidal carriers for drug delivery applications.
Bugnicourt L; Ladavière C
J Control Release; 2017 Jun; 256():121-140. PubMed ID: 28414148
[TBL] [Abstract][Full Text] [Related]
20. Lipid-Drug Conjugates and Nanoparticles for the Cutaneous Delivery of Cannabidiol.
Zielińska A; Cano A; Andreani T; Martins-Gomes C; Silva AM; Szalata M; Słomski R; Souto EB
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
